- Investing Ideas
- Australian Pharmaceuticals & Biotech Healthy potentially undervalued
Australian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
2
0 new
Companies which are potentially undervalued and in an acceptable financial position.
2 companies
Clinuvel Pharmaceuticals
Market Cap: AU$479.1m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$9.59
7D
2.3%
1Y
-21.6%
Radiopharm Theranostics
Market Cap: AU$52.1m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.012
7D
-7.7%
1Y
-51.0%